CIK 0001704292 · Large accelerated filer
Zai Lab Ltd
Sign in to watch- Ticker
- ZLAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 862161632588
- Business address
- 899 HALEI ROAD, BUILDING B, PUDONG, SHANGHAI, China
- Former names
- Zai Lab Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,020
- in 1 filing, $7K under 10b5-1 plans
Net −$7,020. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-26 | Du Ying Chairperson & CEO | Gift | −19,857 | 1,246,426 | ||
| 2026-05-19 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +261,092 | $1.74 | $454K | 1,383,718 |
| 2026-05-19 | Du Ying Chairperson & CEO | Shares withheld for taxes 10b5-1 | −117,435 | $18.75 | $2.2M | 1,266,283 |
| 2026-05-19 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −261,092 | 0 | ||
| 2026-05-18 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $1.74 | $87K | 1,172,626 |
| 2026-05-18 | Du Ying Chairperson & CEO | Sale 10b5-1 | −50,000 | $19.00 | $950K | 1,122,626 |
| 2026-05-18 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 261,092 | ||
| 2026-05-15 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $1.74 | $87K | 1,172,626 |
| 2026-05-15 | Du Ying Chairperson & CEO | Sale 10b5-1 | −50,000 | $20.74 | $1.0M | 1,122,626 |
| 2026-05-15 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 311,092 | ||
| 2026-05-14 | Edmondson Frazor Titus III Chief Legal Officer | Sale 10b5-1 | −3,517 | $20.19 | $71K | 19,849 |
| 2026-05-14 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $1.74 | $87K | 1,172,626 |
| 2026-05-14 | Du Ying Chairperson & CEO | Sale 10b5-1 | −50,000 | $20.09 | $1.0M | 1,122,626 |
| 2026-05-14 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 361,092 | ||
| 2026-05-13 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $1.74 | $87K | 1,172,626 |
| 2026-05-13 | Du Ying Chairperson & CEO | Sale 10b5-1 | −16,231 | $19.44 | $316K | 1,156,395 |
| 2026-05-13 | Du Ying Chairperson & CEO | Sale 10b5-1 | −33,769 | $20.22 | $683K | 1,122,626 |
| 2026-05-13 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 411,092 | ||
| 2026-05-11 | Wang Yizhe Operating Partner | Grant or award · Stock Option (Right to Buy) | +136,819 | 136,819 | ||
| 2026-05-11 | Wang Yizhe Operating Partner | Grant or award · Restricted Share Units | +59,288 | 59,288 |
Page 3 of 15 · 295 trades